NASDAQ:ASPE Aspen Neuroscience (ASPE) Stock Price, News & Analysis $12.59 -1.02 (-7.49%) As of 11/13/2026 04:00 PM Eastern Add Share Share Stock Analysis Stock AnalysisChartInsider TradesSEC Filings About Aspen Neuroscience Stock (NASDAQ:ASPE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aspen Neuroscience alerts:Sign Up Key Stats Today's Range$12.07▼$14.0750-Day Range N/A52-Week Range$11.20▼$14.90Volume173,575 shsAverage Volume428,389 shsMarket Capitalization$366.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aspen Neuroscience, Inc. is a biotechnology company focused on developing regenerative medicine therapies for neurological disorders. The company’s approach uses a patient’s own cells to create induced pluripotent stem cells, which are then differentiated into specialized cells intended to replace damaged or lost tissue. Aspen’s lead program, ANPD001, is designed as a potential cell replacement therapy for Parkinson’s disease. The company has also developed genetic screening and manufacturing processes intended to evaluate a patient’s cells and produce an individualized therapeutic product. Aspen Neuroscience is headquartered in San Diego, California. Publicly available information about its broader product pipeline, geographic operations, and current leadership is limited, and the company’s corporate and trading details should be independently verified.AI Generated. May Contain Errors. Read More Receive ASPE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspen Neuroscience and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASPE Stock News HeadlinesAspen Neuroscience Inc (ASPE)November 12 at 2:15 PM | investing.comAspen Neuroscience Insider Bought Shares Worth $15,000,000, According to a Recent SEC FilingNovember 6, 2026 | marketscreener.comMToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 14 at 1:00 AM | Behind the Markets (Ad)Aspen Neuroscience (NASDAQ:ASPE) Stock: Insider Orbimed Advisors Llc Acquires 1,000,000 SharesNovember 6, 2026 | americanbankingnews.comAspen Neuroscience (NASDAQ:ASPE) Stock: Insider Peter Thompson Buys 1,000,000 SharesNovember 5, 2026 | insidertrades.comInsider Buying: Aspen Neuroscience (NASDAQ:ASPE) Major Shareholder Acquires $1,999,995.00 in StockNovember 4, 2026 | insidertrades.comAspen Neuroscience (NASDAQ:ASPE) Major Shareholder Venture Fund L.P. Arch Acquires 1,200,000 Shares of Company StockNovember 3, 2026 | americanbankingnews.comAspen Neuroscience (NASDAQ:ASPE) Stock: Insider Venture Fund L.P. Arch Purchases 1,200,000 SharesNovember 3, 2026 | insidertrades.comSee More Headlines ASPE Stock Analysis - Frequently Asked Questions How have ASPE shares performed this year? Aspen Neuroscience's stock was trading at $14.89 on October 30, 2026. Since then, ASPE shares have decreased by 15.4% and is now trading at $12.59. When did Aspen Neuroscience IPO? Aspen Neuroscience (ASPE) raised $150 million in an IPO on Friday, October 30th 2026. The company issued 9,375,000 shares at a price of $15.00-$17.00 per share. Leerink Partners, Piper Sandler, Stifel, UBS Investment Bank and Oppenheimer & Co. served as the underwriters for the IPO. When does Aspen Neuroscience's quiet period expire? Aspen Neuroscience's quiet period expires on Wednesday, December 9th. Aspen Neuroscience had issued 9,375,000 shares in its IPO on October 30th. The total size of the offering was $140,625,000 based on an initial share price of $15.00. During Aspen Neuroscience's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. How do I buy shares of Aspen Neuroscience? Shares of ASPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/14/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPE CIK2124080 Webwww.aspenneuroscience.com Phone(858) 263-1222FaxN/AEmployees120Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares29,080,000Free FloatN/AMarket Cap$366.12 million OptionableN/A BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:ASPE) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspen Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspen Neuroscience With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASPE Stock Alerts